Management of the neuropathic bladder by suprapubic catheterisation.
Forty out-patients with neuropathic bladders managed by suprapubic catheterisation have been reviewed. Management included anticholinergic therapy and daily clamping of the catheter to maintain a compliant bladder of good capacity. Twenty-three females and 17 males (mean age 45 years) were studied. Failed intermittent catheterisation and the replacement of long-term urethral catheters were the main indications for suprapubic catheterisation. Catheter-related problems were common, with only 5 patients reporting none. Acceptance by patients was high (84%). No evidence could be found of accelerated renal deterioration in patients followed up for more than 2 years. A policy for the management of suprapubic catheters is recommended.
Barnes
D G
DG
Institute of Urology, London.
Shaw
P J
PJ
Timoney
A G
AG
Tsokos
N
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003250:Constriction; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D017060:Patient Satisfaction; D013119:Spinal Cord Injuries / Q000150:complications; D001750:Urinary Bladder, Neurogenic / Q000209:etiology / Q000628:therapy*; D014546:Urinary Catheterization / Q000009:adverse effects / Q000379:methods* / Q000523:psychology
D010276:Parasympatholytics